ABBV Latest Headlines

Analysts’ Top Healthcare Picks: Nurix Therapeutics (NRIX), AbbVie (ABBV)

at www.tipranks.com (Mon, 9-Nov 9:10 PM)

Quantum Computing News: IBM Unveils New System, Pasqal Sales Plunge 42%

at www.tipranks.com (Mon, 9-Nov 9:35 AM)

AbbVie reports improved facial satisfaction among weight-loss drug users

at seekingalpha.com (Sun, 8-Nov 8:33 PM)

AbbVie’s QULIPTA Beat Topiramate on Both Dropouts and Migraine-Day Reductions in Phase 3 TEMPLE Trial

Market Chameleon (Thu, 29-Oct 8:09 AM)

AbbVie’s Phase 3 INTREPID trial posts a 31.4% HiSCR75 response at Week 16 for lutikizumab in hidradenitis suppurativa

Market Chameleon (Thu, 22-Oct 9:21 AM)

AbbVie Highlights Phase 3 AFFIRM Data as Subcutaneous SKYRIZI Reaches 35.80% Endoscopic Remission in Crohn’s Disease

Market Chameleon (Wed, 14-Oct 9:31 AM)

AbbVie Expands Long-Term Support with $6 Million Immunology Scholarship, Now Marking a Decade of Impact

Market Chameleon (Tue, 18-Aug 9:44 AM)